Cytopenia Study Recruits Participants

The road to recovery after a bone marrow transplant can be complicated by cytopenia(s) (when one or more of your blood cell types is lower than normal). Sometimes this is “immune-mediated,” meaning your red cells or platelets are being targeted and destroyed by the body’s immune system. NHLBI researchers are testing the drug fostamatinib in adults with immune-mediated cytopenia(s) to see whether it will help. The study enrolls adults who are ≥ 60 days post-transplant, experiencing hard-to-treat cytopenia(s) and are transfusion dependent. If interested, contact the Office of Patient Recruitment at (866) 444-2214 (TTY users dial 711), ccopr@nih.gov. Ask for study #000758-H. Online: https://go.nih.gov/ASCoxKs.

Study Seeks Pregnant Women

A research study at NHLBI is looking for pregnant women with sickle cell disease between ages 18 and 45 who are at risk of having an infant with sickle cell disease to donate their baby’s cord blood. Tests and procedures provided at no cost. Contact the Office of Patient Recruitment at (866) 444-2214 (TTY users dial 711) or ccopr@nih.gov. Refer to study #01-H-0122. Online: https://go.usa.gov/xSQqW.